Ibrahim Tarik Ozbolat

Ibrahim Tarik Ozbolat, PhD is a Professor in both Engineering Science and Mechanics and the Department of Neurosurgery at Penn State University. He holds affiliations with the Penn State Cancer Institute, Mechanisms of Carcinogenesis Center, and Center for Neural Engineering. With over 170 research outputs spanning from 2009 to 2025, Dr. Ozbolat has established himself as a leading researcher in bioprinting and tissue engineering technologies.

Dr. Ozbolat's research focuses primarily on bioprinting applications for tissue engineering and regenerative medicine. His work encompasses 3D bioprinting, tissue scaffolds, bioink development, biomaterials, and biofabrication engineering. The fingerprint analysis of his work shows strong emphasis on bioprinting (100%), 3D bioprinting (52%), tissue scaffolds (33%), and tissue engineering (25%). His research contributes to UN Sustainable Development Goals related to health and well-being.

Analysis of his recent publications reveals a strong trend toward increasingly sophisticated bioprinting applications, particularly in skin bioprinting, lung models, and responsive biomaterials. His 2025 publications demonstrate advancements in droplet-based bioprinting, microgel technologies, and functional hydrogels, indicating a trajectory toward more complex, multi-functional tissue constructs with medical applications.

Dr. Ozbolat has secured substantial research funding with 9 total grants and projects, including 3 currently active. His major projects include '3D Printing of Air: An Intangible Ink for Fabrication of Vascularized Tissues' (NIBIB, 2024-2026), 'High-throughput Spheroid Bioprinting Technology for Scalable Fabrication of Tissues' (NIBIB, 2023-2026), and 'Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction' (NIDCR, 2020-2024).

With an h-index of 53 and over 12,302 citations, Dr. Ozbolat maintains an active research program with consistent publication output, showing 11 research outputs in 2024 and 6 already in 2025. His work demonstrates strong interdisciplinary collaboration across engineering, medicine, and basic science domains.